Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
NuvOx LLC
Leica Microsystems (Schweiz) AG
Dysplasia Diagnostics Limited
Massive Bio, Inc.
Ourotech, Inc.
NovoCure Ltd.
Taproot Health
Ascension Health
Power Life Sciences Inc.
Power Life Sciences Inc.
KIYATEC
xCures
NovoCure Ltd.
OncoHost Ltd.
NovoCure Ltd.
SpeciCare
Eisai Inc.
Hoffmann-La Roche
CANbridge Life Sciences Ltd.
Eisai Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Genentech, Inc.
Merck Sharp & Dohme LLC
Oncoscience AG